Aprea Therapeutics annual free cash flow
2018
2019
2020
2023
2024
Aprea Therapeutics Free Cash Flow (FCF) History (APRE)
Aprea Therapeutics reported −$13.6M in free cash flow for fiscal 2024, a decrease of $1.3M from the previous fiscal year.
View full Aprea Therapeutics company overviewAprea Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$13.6M | −$1.3M | — | — |
| 2023 | 2023-12-31 | −$12.3M | $29.6M | — | — |
| 2020 | 2020-12-31 | −$41.8M | −$15.1M | — | — |
| 2019 | 2019-12-31 | −$26.7M | −$11.5M | — | — |
| 2018 | 2018-12-31 | −$15.3M | — | — | — |
Aprea Therapeutics quarterly free cash flow
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$3.5M | $9.7M | — | — |
| Q3 2024 | 2024-09-30 | −$2.5M | $9.0M | — | — |
| Q2 2024 | 2024-06-30 | −$3.6M | $6.0M | — | — |
| Q1 2024 | 2024-03-31 | −$3.9M | $3.6M | — | — |
| Q4 2020 | 2020-12-31 | −$13.2M | −$10.4M | — | — |
| Q3 2020 | 2020-09-30 | −$11.4M | — | — | — |
| Q2 2020 | 2020-06-30 | −$9.6M | — | — | — |
| Q1 2020 | 2020-03-31 | −$7.6M | — | — | — |
| Q3 2019 | 2019-09-30 | −$2.8M | — | — | — |
Aprea Therapeutics free cash flow growth trends
Aprea Therapeutics's latest reported quarter, Q4 2024, generated −$3.5M in free cash flow, an increase of $9.7M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Aprea Therapeutics filings at SEC.gov ↗